Finally, Zhao et al. showed that the treatment with FOXD3-AS1 construct or with siRNAs against PARP1 or CTCF reduces tumor growth and extends mice xenografts’ survival, confirming the causal relationship between these molecules. This evidence concerns the gene FOXD3 and neoplasm.